scispace - formally typeset
M

Mohammad Ajmal Ali

Researcher at King Saud University

Publications -  73
Citations -  819

Mohammad Ajmal Ali is an academic researcher from King Saud University. The author has contributed to research in topics: Chemistry & Medicine. The author has an hindex of 9, co-authored 61 publications receiving 386 citations.

Papers
More filters
Journal ArticleDOI

Silver nanoparticles synthesized from Adenium obesum leaf extract induced DNA damage, apoptosis and autophagy via generation of reactive oxygen species.

TL;DR: In this article, the authors used aqueous leaf extract of A. obesum (AOAgNPs) for the synthesis of silver nanoparticles, which were further characterized by Fourier transform infrared (FTIR) spectroscopy, X-ray diffraction (XRD) and transmission electron microscopy (TEM).
Journal ArticleDOI

Unravelling lead antiviral phytochemicals for the inhibition of SARS-CoV-2 Mpro enzyme through in silico approach.

TL;DR: Bonducellpin D exhibited broad-spectrum inhibition potential against SARS- CoV Mpro and MERS-CoV M Pro and therefore is a promising drug candidate, which needs further validations through in vitro and in vivo studies.
Journal ArticleDOI

An Updated Review of Computer-Aided Drug Design and Its Application to COVID-19.

TL;DR: In this paper, the authors highlight two important categories of computer-aided drug design (CADD), viz., the ligand-based as well as structured-based drug discovery.
Journal ArticleDOI

Structure-based virtual screening of phytochemicals and repurposing of FDA approved antiviral drugs unravels lead molecules as potential inhibitors of coronavirus 3C-like protease enzyme

TL;DR: The present work aimed at the identification of suitable lead molecules for the inhibition of 3CLpro enzyme via a computational screening of the Food and Drug Administration (FDA) approved antiviral drugs and phytochemicals.
Journal ArticleDOI

Exploring the physicochemical profile and the binding patterns of selected novel anticancer Himalayan plant derived active compounds with macromolecular targets

TL;DR: Novel anti-cancer plants derived compounds from Himalayan region were docked with defined molecular targets that regulate cell proliferation and apoptosis and Physicochemical profile studies showed that majority of the compounds conform to Lipinski's rule of five having low to high blood brain barrier penetration, human intestinal absorption, plasma binding protein inhibition and P glycoprotein inhibition.